Efficacy of rapamycin and sodium phenylbutyrate in a xenograft model of IBM
Awardee: Thomas Lloyd
Institution: Johns Hopkins University
Award Amount: $68,245
Funding Period: February 1, 2021 - January 31, 2022
Previous
Previous
Dissecting the Genetic and Genomic Basis of Neuroendocrine Cell Hyperplasia of Infancy (NEHI)
Next
Next